Occupier

Find Out The Latest

You can keep in touch with exciting developments for The Oxford Science Park and its occupiers here.

You can also keep up to date by following us on Twitter or LinkedIn

Oxford University & Vaccitech welcome UK regulatory emergency use authorisation of coronavirus vaccine

30 Dec 2020

Oxford, UK – Vaccitech Ltd announces that the UK Government has today accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK. The vaccine was co-invented by Vaccitech and The University of Oxford’s Jenner Institute. The Joint Committee on Vaccination and Immunisation (JCVI) will... Read more

Enara Bio relocates to The Oxford Science Park’s newest facility to expand R&D capabilities in the search for novel cancer immunotherapies

09 Dec 2020

Oxford and London, UK – 9th December 2020. Enara Bio, a biotechnology company leveraging its proprietary T-cell/T-cell receptor (TCR) discovery and Dark Antigen™ platforms to deliver targeted cancer immunotherapies, announces its expansion and move to the new Bellhouse Building at The Oxford Science Park. Enara’s move from the Oxford BioEscalator to one of the UK’s largest biomedical innovation centres is in preparation for its future growth... Read more

Innovate UK backs ATDBio & University of Oxford research in single-cell sequencing

08 Sep 2020

New approach expected to increase use of technique in research and diagnosis Oxford, UK, September 8 2020 – ATDBio, a leader in complex oligonucleotide synthesis, and a research team at the Botnar Research Centre, University of Oxford, have been awarded funding by Innovate UK, the UK’s Innovation Agency, to improve single-cell RNA sequencing (scRNA-Seq). By developing new materials for scRNA-Seq, the partners expect to increase its use in... Read more

Oxford Nanopore Technologies partners with UK Government to roll out LamPORE, a new generation of COVID-19 test

03 Aug 2020

Mon 3rd August 2020 Ground-breaking British technology will initially provide hundreds of thousands of fast, accurate, low-cost COVID-19 tests under new agreement with the UK Government, with the potential to build to millions of tests per month The “LamPORE COVID-19” assay provides precise detection of SARS-CoV-2, the virus that causes COVID-19, using Oxford Nanopore’s DNA/RNA sequencing technology. LamPORE is fully scalable and... Read more

Innovate UK grant to further development of OrthoSon ultrasound technology in back pain

29 Jul 2020

Innovate UK grant to further development of ultrasound technology in back pain Data from extended Biomedical Catalyst award to support progression of OrthoSon technology towards first-in-human trial Oxford, UK, July 29 2020 – OrthoSon, an Oxford University spin-out which is developing a novel ultrasound-based treatment for lower back and neck pain, has been awarded a £250,000 extension to its £1.2m Biomedical Catalyst award. The extension,... Read more

News